Octahydrocondensed azadecalin glucocorticoid receptor regulator

JP2026094404APending Publication Date: 2026-06-09CORCEPT THERAPEUTICS INC

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
CORCEPT THERAPEUTICS INC
Filing Date
2026-03-10
Publication Date
2026-06-09

Smart Images

  • Figure 2026094404000001_ABST
    Figure 2026094404000001_ABST
Patent Text Reader

Abstract

To provide novel compositions and methods for modulating GR receptors. [Solution] The present invention provides an octahydrocondensed azadecalin compound and a method for using the compound as a glucocorticoid receptor modulator. In some embodiments, the present invention provides a pharmaceutical composition comprising the compound of the present invention and a pharmaceutically acceptable excipient. In some embodiments, the present invention provides a method for modulating a glucocorticoid receptor, the method comprising the step of contacting the glucocorticoid receptor with the compound of the present invention, thereby modulating the glucocorticoid receptor.
Need to check novelty before this filing date? Find Prior Art

Claims

[Claim 1] The need for a method for modulating GR receptors.